Takis disposes of a large collection (>100) of human and murine cancer cell lines. We can analyze the effects of drugs and the connected molecular events. Cells can also be engineered to knock-down a target of interest and evaluate its biological role.
Tumor initiating cells from lung adenocarcinoma pleural effusions
In close collaboration with Dept. of Clinical and Experimental Medicine, Laboratory of Surgery, University of Rome La Sapienza, we have set up and optimized methods to isolate Tumor Initiating Cells (TICs) from primary tumors: an exceptional tool for personalized medicine and to test novel drugs and combination therapies.
Drug Testing on TICs
If you want to assess the efficacy on cancer cells with stem potential, Takis offer the Drug testing services on Tumor Initiating Cells